Renal Cancer - Results from #4880

Practical management of adverse events associated with cabozantinib treatment in patients with renal-cell carcinoma November 10, 2017

Position paper: Rationale for the treatment of Wilms tumour in the UMBRELLA SIOP-RTSG 2016 protocol November 10, 2017

Patient-specific molecular alterations are associated with metastatic clear cell renal cell cancer progressing under tyrosine kinase inhibitor therapy November 10, 2017

Integrative Analysis of Histopathological Images and Genomic Data Predicts Clear Cell Renal Cell Carcinoma Prognosis November 9, 2017

Accompanying role of hepato-biliary-pancreas surgeon in urological surgery November 9, 2017

Immune-Related Adverse Events Associated with Anti-PD-1/PD-L1 Treatment for Malignancies: A Meta-Analysis November 9, 2017

SETDB2 and RIOX2 are differentially expressed among renal cell tumor subtypes, associating with prognosis and metastization November 8, 2017

Renin angiotensin system deregulation as renal cancer risk factor November 8, 2017

Positive surgical margin following radical nephrectomy is an independent predictor of local recurrence and disease-specific survival November 8, 2017

Upregulation of FBXW7 Suppresses Renal Cancer Metastasis and Epithelial Mesenchymal Transition November 7, 2017

Insights into Epigenetic Remodeling in VHL-Deficient Clear Cell Renal Cell Carcinoma November 7, 2017

[Retrospective comparison of the reproducibility and the performances of R.E.N.A.L. score, 12 segments score and UPRCC score for the partial nephrectomy] November 7, 2017

Whole Blood mRNA Expression-Based Prognosis of Metastatic Renal Cell Carcinoma November 6, 2017

Perirenal Abscess After Partial Nephrectomy Because of Migration of Upper Calix Stone and Urine Leakage: A Case Report November 6, 2017

Renal Cell Carcinoma With Leiomyomatous Stroma: A Group of Tumors With Indistinguishable Histopathologic Features, But 2 Distinct Genetic Profiles: Next-Generation Sequencing Analysis of 6 Cases Negative for Aberrations Related to the VHL gene November 5, 2017

Combination of mTOR and MAPK Inhibitors-A Potential Way to Treat Renal Cell Carcinoma November 5, 2017

Common, germline genetic variations in the novel tumor suppressor BAP1 and risk of developing different types of cancer November 4, 2017

Strategies for success: A multi-institutional study on robotic partial nephrectomy for complex renal lesions November 3, 2017

A practical guide and decision-making protocol for the management of complex renal cystic masses November 3, 2017

Renal cell carcinoma histological subtype distribution differs by age, gender, and tumor size in coastal Chinese patients November 3, 2017

Page 245 of 458